185 related articles for article (PubMed ID: 26251517)
1. A p7 Ion Channel-derived Peptide Inhibits Hepatitis C Virus Infection in Vitro.
Hong W; Lang Y; Li T; Zeng Z; Song Y; Wu Y; Li W; Cao Z
J Biol Chem; 2015 Sep; 290(38):23254-63. PubMed ID: 26251517
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target.
Khaliq S; Jahan S; Hassan S
Liver Int; 2011 May; 31(5):606-17. PubMed ID: 21457434
[TBL] [Abstract][Full Text] [Related]
3. A human claudin-1-derived peptide inhibits hepatitis C virus entry.
Si Y; Liu S; Liu X; Jacobs JL; Cheng M; Niu Y; Jin Q; Wang T; Yang W
Hepatology; 2012 Aug; 56(2):507-15. PubMed ID: 22378192
[TBL] [Abstract][Full Text] [Related]
4. Computational Study of HCV p7 Channel: Insight into a New Strategy for HCV Inhibitor Design.
Ying B; Pang S; Yang J; Zhong Y; Wang J
Interdiscip Sci; 2019 Jun; 11(2):292-299. PubMed ID: 30194627
[TBL] [Abstract][Full Text] [Related]
5. Computational Docking Study of p7 Ion Channel from HCV Genotype 3 and Genotype 4 and Its Interaction with Natural Compounds.
Mathew S; Fatima K; Fatmi MQ; Archunan G; Ilyas M; Begum N; Azhar E; Damanhouri G; Qadri I
PLoS One; 2015; 10(6):e0126510. PubMed ID: 26030803
[TBL] [Abstract][Full Text] [Related]
6. Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7.
Walter S; Bollenbach A; Doerrbecker J; Pfaender S; Brown RJP; Vieyres G; Scott C; Foster R; Kumar A; Zitzmann N; Griffin S; Penin F; Pietschmann T; Steinmann E
J Virol; 2016 May; 90(10):5075-5089. PubMed ID: 26962224
[TBL] [Abstract][Full Text] [Related]
7. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
[TBL] [Abstract][Full Text] [Related]
8. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
[TBL] [Abstract][Full Text] [Related]
9. "Too little, too late?" Will inhibitors of the hepatitis C virus p7 ion channel ever be used in the clinic?
Griffin S
Future Med Chem; 2014; 6(17):1893-907. PubMed ID: 25495983
[TBL] [Abstract][Full Text] [Related]
10. A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity in mammalian cells but is dispensable for localization to mitochondria.
Griffin SDC; Harvey R; Clarke DS; Barclay WS; Harris M; Rowlands DJ
J Gen Virol; 2004 Feb; 85(Pt 2):451-461. PubMed ID: 14769903
[TBL] [Abstract][Full Text] [Related]
11. Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production.
Wozniak AL; Griffin S; Rowlands D; Harris M; Yi M; Lemon SM; Weinman SA
PLoS Pathog; 2010 Sep; 6(9):e1001087. PubMed ID: 20824094
[TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Properties of the Hepatitis C Virus p7 Viroporin.
Madan V; Bartenschlager R
Viruses; 2015 Aug; 7(8):4461-81. PubMed ID: 26258788
[TBL] [Abstract][Full Text] [Related]
13. Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channel.
Foster TL; Verow M; Wozniak AL; Bentham MJ; Thompson J; Atkins E; Weinman SA; Fishwick C; Foster R; Harris M; Griffin S
Hepatology; 2011 Jul; 54(1):79-90. PubMed ID: 21520195
[TBL] [Abstract][Full Text] [Related]
14. In depth analysis on the binding sites of adamantane derivatives in HCV (hepatitis C virus) p7 channel based on the NMR structure.
Du QS; Wang SQ; Chen D; Meng JZ; Huang RB
PLoS One; 2014; 9(4):e93613. PubMed ID: 24714586
[TBL] [Abstract][Full Text] [Related]
15. Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel.
Griffin S; Stgelais C; Owsianka AM; Patel AH; Rowlands D; Harris M
Hepatology; 2008 Dec; 48(6):1779-90. PubMed ID: 18828153
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus p7 mediates membrane-to-membrane adhesion.
Lee GY; Lee S; Lee HR; Yoo YD
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1096-1101. PubMed ID: 27320856
[TBL] [Abstract][Full Text] [Related]
17. A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.
Cheng G; Montero A; Gastaminza P; Whitten-Bauer C; Wieland SF; Isogawa M; Fredericksen B; Selvarajah S; Gallay PA; Ghadiri MR; Chisari FV
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3088-93. PubMed ID: 18287023
[TBL] [Abstract][Full Text] [Related]
18. The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives.
Pavlović D; Neville DC; Argaud O; Blumberg B; Dwek RA; Fischer WB; Zitzmann N
Proc Natl Acad Sci U S A; 2003 May; 100(10):6104-8. PubMed ID: 12719519
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HCV p7 as a therapeutic target.
Griffin S
Curr Opin Investig Drugs; 2010 Feb; 11(2):175-81. PubMed ID: 20112167
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor Development against p7 Channel in Hepatitis C Virus.
Wei S; Hu X; Du L; Zhao L; Xue H; Liu C; Chou JJ; Zhong J; Tong Y; Wang S; OuYang B
Molecules; 2021 Mar; 26(5):. PubMed ID: 33802584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
